Brovincamine fumarate
- Level
- Commodity
- Parent
- 51411700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51411708This classification denotes a vasodilating agent C21H25BrN2O3.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y3SNC78UTU, chemically known as eburnamenine-14-carboxylic acid, 14,15-dihydro-11-bromo-14-hydroxy-, methyl ester, (3-.alpha.,14-.beta.,16-.alpha.)-, (e)-2-butenedioate (1:1) (salt), but more generally known as brovincamine fumarate, which bears US NIH Compound Identifier 5282434. European Medicines Agency schedules Brovincamine fumarate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00883MIG. Most nations, for tariff and trade purposes, schedule brovincamine fumarate under HS 29399900 and SITC 54149. As of Q4 2014, BROVINCAMINE FUMARATE remains US FDA's Preferred Term for this commodity. SMILES: CC[C@@]12CCCN3[C@@H]1C4C(C5CCC(CC5N4[C@](C2)(C(=O)OC)O)BR)CC3.C(=C/C(=O)O)\C(=O)O.
Same parent
Under 51411700 · 13Activities that produce or sell this
KBLI · 8Inherited from family 51410000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.